Enter your login e-mail to the account
Search
Search parameters
Search results
- Sekundární dyslipoproteinémie
MUDr. Michal Vrablík, PhD., doc. MUDr. Richard Češka, CSc.
(1/2004, Main topic ) - Současnost a perspektivy léčby dyslipidémií
doc. MUDr. Jan Bultas, CSc., MUDr. Debora Karetová
(1/2004, Main topic ) - MAGNESIUM AND ITS IMPORTANCE FOR THE CLINICAL PRACTISE
MUDr. Vladimír Pavlišák, prof. MUDr. Ivica Lazúrová, CSc.
(1/2006, Memorix ) - Epidemiologic situation in Slovakia – circulation disorders and their risk factors
MUDr. Anna Baráková
(1/2009, Topic of the year ) - SECONDARY PREVENTION IN ACUTE MYOCARDIAL INFARCTION
MUDr. Branislav Tomašovič, MUDr. Marián Kozlovský
(1/2006, Topic ) - Chronic kidney disease – role of nephrologist and general practitioner
Prof. MUDr. Romana Ryšavá, CSc.
(2/2015, Interdisciplinary consilium ) - Podľa medzinárodnej akademickej nadácie R3i prináša ACCORD Lipid novú nádej diabetikom 2. typu s aterogénnou dyslipidémiou
MUDr. Ľubomíra Fábryová, PhD.
(2/2010, Topic of the year ) - The choice of antidiabetic medications with regard to metabolic syndrome
doc. MUDr. Alena Šmahelová, PhD.
(11/2009, Review articles ) - The Importance of Omega – 3 Fatty Acids in the Treatment of Dyslipidemia
prof. MUDr. Daniel Pella, PhD.
(12/2009, Topic of the year ) - Komentár k odporúčaniam ACC/AHA (ACC/AHA Guidelines on the Treatment of Blood Cholesterol)
MUDr. Ľubomíra Fábryová, PhD., prof. MUDr. Andrej Dukát, CSc., FESC
(2/2014, Information & comments ) - Combined hypolipidemic therapy in current clinical practice
MUDr. Ľubomíra Fábryová, PhD.
(6/2014, Review articles ) - Adherence and how to influence it
doc. MUDr. Michal Vrablík, Ph.D.
(2/2014, Review articles ) - NOVÉ TRENDY V PREVENCII ATEROSKLERÓZY
(3/2007, Events ) - Comparison of efficacy and safety of atorvastatin in a dosage of 20 mg and 30 mg in general practitioners’ practice
MUDr. Martin Čaprnda, PhD., Mgr. Ján Farkašovský, PharmDr. Silvia Encingerová, Mgr. Oliver Tlčimuka
(5/2016, Original articles & case reports ) - Reach target LDL cholesterol more effective dose of atorvastatin 30 mg in the practice of general practitioners
MUDr. Martin Čaprnda, PhD., MUDr. Ján Hencel, MSc., Mgr. Ján Farkašovský, PharmDr. Silvia Encingerová, Mgr. Oliver Tlčimuka
(5/2015, Original articles & case reports ) - Physical exercise – mandatory part of complex dyslipidemia managment
prof. MUDr. Dušan Meško, PhD.
(7-8/2009, Topic of the year ) - DIABETIC DYSLIPIDAEMIA – IMPORTANT PART OF THE COMPLEX CARE FOR THE PATIENTS WITH DIABETES TYPE 2
MUDr. Ľubomíra Fábryová
(1/2005, Topic ) - Adiposopathic dyslipidaemia
MUDr. Ľubomíra Fábryová, PhD., MPH
(6/2021, Topic of the year ) - MANAGEMENT OF ATHEROGENIC DYSLIPIDAEMIA IN THE METABOLIC SYNDROME
MUDr. Ľubomíra Fábryová
(S4/2007, Supplement ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - METABOLIC SYNDROME, CARDIOVASCULAR AND METABOLIC RISK
prof. MUDr. Peter Galajda, CSc.
(S4/2007, Supplement ) - Practical use of Ů -3 PUFA supplementation in internal medicine
MUDr. Karol Trejbal
(3/2012, Review articles ) - NON-PHARMACOLOGICAL AND PHARMACOLOGICAL POSSIBILITIES IN THERAPY OF OBESE PATIENTS WITH METABOLIC SYNDROME
doc. MUDr. Boris Krahulec, CSc.
(S4/2007, Supplement ) - Metabolic changes after bariatric surgery
MUDr. Pavol Holéczy, CSc., Mgr. Marek Bužga, PhD.
(2/2016, Topic of the year ) - Editoriál
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - Pharmacotherapy of chronic forms of ischemic limb disease according to current guidelines
MUDr. Jiří Holý, MUDr. Martin Holý, MUDr. Zsolt Keczkemethy, MUDr. Kamila Nováková, MUDr. Pavel Havránek
(3/2012, Review articles ) - MANAGEMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH METABOLIC SYNDROME
prof. MUDr. Daniel Pella, PhD., doc. MUDr. Viola Mechírová, CSc.
(S4/2007, Supplement ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - Significance of combined hypolipidemic therapy for patients with metabolic syndrome
MUDr. Renáta Palmajová
(3/2010, Original articles & case reports ) - Dyslipidemia and diabetic foot syndrome
doc. MUDr. David Karásek, Ph.D., MUDr. Daniela Číhalíková
(2/2020, Review articles ) - Simultaneous intervention for arterial hypertension and dyslipidaemia
MUDr. Eva Tůmová, Ph.D.
(3/2021, Review articles ) - MANAGING DYSLIPIDAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
MUDr. Ľubomíra Fábryová
(10/2005, Topic ) - Epidemiology and health consequences of obesity
MUDr. Ľubomíra Fábryová, PhD.
(1/2015, Topic of the year ) - Role of niacin in a hypolipidaemic treatment in high cardiovascular risk patients
prof. MUDr. Andrej Dukát, CSc., doc. MUDr. Ľudovít Gašpar, CSc., MUDr. Peter Minárik, doc. MUDr. Martin Wawruch, PhD., doc. MUDr. Stanislav Oravec, CSc., MUDr. Peter Sabaka
(1/2010, Topic of the year ) - How to talk with patient with sexual problems
MUDr. Zlatko Pastor, Ph.D.
(4/2015, Electronic attachment ) - Srovnání účinnosti semi-generického a originálního atorvastatinu
doc. MUDr. Richard Češka, CSc., prof. MUDr. Helena Vaverková, CSc., as. MUDr. Michal Vrablík, PhD., Jitka Housová, Tomáš Štulc, Željko Reiner, Zvonimir Rumboldt
(5/2005, Spectrum ) - Combined hypolipidemic therapy using statins and fibrates reducing the cardiovascular risk in the patients with atherogenic dyslipidemia
prof. MUDr. Vladimír Bláha, CSc.
(4/2010, Topic of the year ) - The role of diet therapy in complex treatment of dyslipoproteinemias
MUDr. Viera Kissová, PhD.
(9/2009, Topic of the year ) - ADJUVANTS IN THE TREATMENT OF CHRONIC PAIN
MUDr. Stanislav Fabuš
(6/2005, Topic ) - XIV. medzinárodné sympózium o ateroskleróze v Ríme
MUDr. Ľubomíra Fábryová
(9/2006, Events ) - Kompetencie všeobecného lekárstva – neverending story?
prof. MUDr. Ján Gajdošík, PhD.
(1/2014, Focus ) - SPRÁVA Z XVIII. DIABETOLOGICKÝCH DNÍ 28. – 30. MÁJ 2008, KOŠICE
MUDr. Slávka Kalinová, PhD.
(7-8/2008, Events ) - IDEA – THE FIRST RESULTS ABOUT PREVALENCE OF ABDOMINAL OBESITY IN SLOVAKIA
prof. MUDr. Andrej Dukát, CSC., FESC, doc. MUDr. Ján Lietava, CSc., doc. MUDr. Boris Krahulec, CSc., doc. MUDr. Jozef Glasa, CSc., MUDr. Viera Kosmálová
(12/2006, Topic ) - Prevention or sloving the progression of diabetic nephropathy. Fact or fiction?
MUDr. Vladimír Uličiansky
(4/2016, Review articles ) - The possibillities in the treatment of arterial hypertension in the elderly
MUDr. Karol Trejbal
(2/2013, Review articles ) - MANAGEMENT OF THE PATIENTS WITH CHRONIC HEART FAILURE AND DECREASED RENAL FUNCTION
MUDr. Filip Málek, MUDr. Martin Havrda
(12/2008, clearly ) - RELATIONSHIP OF VISCERAL OBESITY TO CARDIOMETABOLIC RISK FACTORS
MUDr. Ľubomíra Fábryová, PhD.
(3/2008, Topic ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(3/2008, Topic )
- METABOLIC SYNDROME AND SELECTED MENTHAL ILLNESSES
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(4/2008, Review articles ) - Treatment with atypical antipsychotic drugs and their selection based on the spectrum of side effects
doc. MUDr. Radovan Přikryl, Ph.D.
(1/2009, Review articles ) - RISK FACTORS CONCERNING THE LIFESTYLE OF PATIENS SUFFERING FROM SCHIZOPHRENIA
MUDr. Klára Látalová, Ph.D., MUDr. Zuzana Sigmundová
(1/2008, Review articles ) - Atypical antipsychotics and diabetes mellitus
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(1/2013, Review articles ) - Metabolic syndrome in the context of psychiatric disorders and psychotropic treatment
MUDr. Jozef Dragašek, PhD.
(1/2014, Review articles ) - Prevention of cardiovascular risk and diabetes in schizophrenia patients: application of internet in clinical praxis
MUDr. Jiří Masopust, Ph.D., MUDr. Radovan Malý, Ph.D.
(5–6/2010, In short ) - ANTIPSYCHOTICS TREATMENT AND METABOLIC SYNDROME
MUDr. Dita Kalnická, prof. MUDr. Jan Libiger, CSc.
(5/2006, Review articles ) - Ziprasidone treatment and metabolic parameters changes
MUDr. Jozef Dragašek, PhD., MUDr. Simona Líšková
(2/2011, Original articles & case reports ) - Influence of antidepressant on body weight
prof. MUDr. Eva Češková, CSc.
(5/2009, Review articles ) - METABOLIC SYNDROME IN PSYCHIATRY
doc. MUDr. Vladimír Pidrman, Ph.D., doc. MUDr. Jiří Horáček, CSc.
(5/2005, Review articles ) - DEPRESSION, METABOLIC SYNDROME AND DIABETES MELLITUS
MUDr. Jiří Podlipný, MUDr. Zdeněk Hess
(2/2006, Review articles )
- Publikujeme v zahraničí
doc. MUDr. Milan Brázdil, Ph.D. , MUDr. Roman Herzig, Ph.D.
(5/2006, Papers from literature ) - Neurologické projevy poruch metabolizmu lipidů
doc. MUDr. Ivanka Vlachová
(1/2005, Main topic )
- Komplex metabolic changes in children with obesity
MUDr. Zlatko Marinov, MUDr. Dalibor Pastucha, Ph.D., MBA
(2/2012, Review articles ) - Pediatria pre prax – 55. pediatrické dni
MUDr. Michaela Bednarčíková, MUDr. Marek Smoleňák
(3/2015, Events ) - Health and psychosocial consequences of obesity in children and adolescents
MUDr. Irena Aldhoon Hainerová, Ph.D., RNDr. Hana Zamrazilová, Ph.D.
(3/2016, Review articles )
- Late toxicity in patients with testicular germ cell tumors
MUDr. Michaela Sojáková, MUDr. Katarína Rejleková, PhD.
(3/2016, Main topic )
- Cardiovascular diseases and psoriasis
MUDr. Zuzana Baranová, PhD.
(3/2016, Review articles ) - Acne – An overview, news in the treatment
MUDr. Katařina Fajkošová
(4/2011, Review articles )
- METABOLIC SYNDROME AND SELECTED MENTHAL ILLNESSES
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(4/2008, Review articles ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(2/2008, Review articles )
- Effect of obesity on morbidity
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(3/2012, Clinical pharmacy ) - Safe and effective antihypertensive therapy in obesity
PharmDr. Iva Prokopová, Ph.D.
(4/2016, Clinical pharmacy ) - What can statins do in the management of cardiovascular deseases?
MUDr. Marta Filková, prof. MUDr. Ján Murín, CSc.,, MUDr. Miroslav Pernický
(1/2013, Current pharmacotherapy ) - Medicinal plants in prevention of cardiovascular diseases
PharmDr. Szilvia Czigle, PhD., Mgr. Jaroslav Tóth, PhD.
(1/2014, Phytotherapy ) - Niacin-laropiprant combination: novel approach not only to treatment of dyslipidemia Complex management of dyslipidemia provides a chance of further reduction of atherosclerotic vascular
MUDr. Michal Vrablík, Ph.D., MUDr. Eva Motyková, prof. MUDr. Richard Češka, CSc.
(1/2011, New medicinal substances ) - Dyslipidémie ako rizikový faktor kardiovaskulárnych ochorení: dôraz na familiárnu hypercholesterolémiu, jej včasnú diagnostiku a terapiu
Doc. PharmDr. Adriana Duriš Adameová, PhD.
(2/2018, Current pharmacotherapy ) - Current Possibilities of Dyslipidema Therapy
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(2/2011, Current pharmacotherapy ) - Starostlivosť lekárnika o pacientov s diabetom
PharmDr. Marcel Jusko, PhD.
(2/2013, For pharmaceutical laboratory technicians ) - Pharmacist´s role in educating a patient with diabetes mellitus – part I
PharmDr. Lucia Masaryková, PhD.,, Doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Ľubica Lehocká, PhD.
(1/2017, Clinical pharmacy )
- Periférne artériové ochorenie dolných končatín a globálne kardiovaskulárne riziko – možnosti ovplyvnenia v klinickej praxi
MUDr. Denisa Čelovská, PhD., prof. MUDr. Viera Štvrtinová, CSc., MUC. Mária Balgová
(1/2018, Main topic )